Related Experiment Video

Updated: May 15, 2026

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

Optimizing combination rifampin therapy for staphylococcal osteoarticular infections

Guillaume Coiffier1, Jean-David Albert, Cédric Arvieux

  • 1Service de rhumatologie, hôpital Sud, CHU de Rennes, 16, boulevard de Bulgarie, 35203 Rennes cedex 2, France. guillaume.coiffier@chu-rennes.fr

Joint Bone Spine
|January 22, 2013
PubMed

Insights

Rifampin is crucial for treating Staphylococcus osteoarticular infections, but resistance is a risk. Combining it with other antibiotics, as per French guidelines, is key to successful treatment and preventing relapse.

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Orthopedics

Background:

  • Staphylococcus spp. are the primary cause of osteoarticular infections, often leading to treatment failure due to biofilm formation and persistence.
  • Rifampin is a vital antibiotic for staphylococcal osteoarticular infections, especially those involving implants, due to its bone and biofilm penetration.
  • Rifampin's mechanism inhibits bacterial DNA transcription, effective against dormant bacteria, but resistance necessitates combination therapy.

Purpose of the Study:

  • To review and compare antibiotics used in combination with rifampin for Staphylococcus osteoarticular infections.
  • To analyze the advantages and disadvantages of various antibiotic combinations based on scientific evidence.

Main Methods:

  • Review of in vitro, animal, and clinical studies.
  • Analysis of antibiotic efficacy and resistance patterns.
  • Evaluation of French-Speaking Society for Infectious Diseases (SPILF) guidelines.

Main Results:

  • Rifampin demonstrates excellent efficacy against Staphylococcus spp. in bone and biofilm infections.
  • High risk of rifampin-resistant mutant emergence necessitates combination therapy.
  • Several antibiotics are recommended in combination with rifampin, each with specific benefits and drawbacks.

Conclusions:

  • Combination therapy is essential for managing Staphylococcus osteoarticular infections to prevent resistance.
  • The choice of the second antibiotic should be guided by in vitro data, clinical evidence, and established guidelines.
  • Understanding the pros and cons of each rifampin combination is crucial for optimizing treatment outcomes.

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...